Cagrilindi peptide
Sale

Cagrilindi peptide

Price range: £122.00 through £237.00

Cagrilintide Peptide (10mg) by PEPTIDE MEDICS is a synthetic long-acting amylin analogue studied in metabolic and endocrine research models. Researchers have explored cagrilintide in experimental settings investigating appetite regulation pathways, metabolic signaling, and energy balance mechanisms.

Each vial from PEPTIDE MEDICS contains 10mg of high-purity Cagrilintide in lyophilized form, allowing researchers to examine its properties in controlled laboratory environments.

All peptides offered by PEPTIDE MEDICS are supplied strictly for laboratory research purposes only.

Size
Choose an option
Cagrilindi peptide 5mg
Add to cart
Buy Now

Cagrilintide Research Peptide

Cagrilintide is a long-acting synthetic analogue of amylin, a peptide hormone naturally co-secreted with insulin from pancreatic beta cells. In biological systems, amylin is involved in metabolic signaling processes related to appetite regulation, gastric motility, and glucose metabolism.

In peptide research environments, cagrilintide has attracted scientific interest due to its stability and extended activity compared to natural amylin peptides. These characteristics allow researchers to investigate metabolic pathways and hormonal signaling mechanisms within controlled experimental models.

Scientific Background

Amylin peptides play an important role in metabolic signaling and digestive regulation. Scientists have studied cagrilintide to explore how modified peptide structures may influence biological pathways related to appetite signaling and energy regulation.

Research models investigating cagrilintide often focus on areas such as:

  • Appetite regulation pathways

  • Metabolic signaling mechanisms

  • Energy balance studies

  • Endocrine peptide interactions

  • Gastrointestinal hormone signaling

These areas continue to be explored within modern peptide science and metabolic research.

Research Areas Associated With Cagrilintide

In scientific laboratories, researchers may investigate cagrilintide in studies related to:

  • Metabolic pathway research

  • Hormonal signaling studies

  • Appetite regulation models

  • Energy balance research

  • Endocrine system interactions

Ongoing research continues to expand the understanding of amylin analogues and their role in metabolic signaling.

Product Specifications

Feature Details
Product Name Cagrilintide
Peptide Content 10mg per vial
Form Lyophilized (freeze-dried) powder
Grade Research / Laboratory Grade
Manufacturer PEPTIDE MEDICS
Packaging Sterile sealed research vial
Application Scientific research only

Storage Guidelines

Proper storage is recommended to maintain peptide stability and structural integrity.

Suggested storage conditions:

  • Store in a cool, dry place

  • Refrigeration recommended for extended storage

  • Protect from excessive heat and light exposure

  • Handle with proper laboratory procedures

Following proper storage guidelines helps preserve peptide integrity for research use.

Research Use Disclaimer

All products distributed by PEPTIDE MEDICS are intended strictly for laboratory research purposes only.

These compounds are not intended for human consumption, medical treatment, or veterinary use.

By purchasing from PEPTIDE MEDICS, customers acknowledge that they are qualified researchers and will use these compounds solely within legitimate laboratory settings.

Research References

Researchers interested in learning more about Cagrilintide may review scientific publications and peptide research literature available through biomedical databases such as:

  • PubMed

  • Endocrinology research journals

  • Metabolic and peptide science publications

These resources provide additional context regarding amylin analogues, metabolic peptide signaling, and endocrine research models.

Cagrilindi peptide 5mg Cagrilindi peptide 10mg

Additional Information

Size

5mg, 10mg

Reviews

There are no reviews yet.

Be the first to review “Cagrilindi peptide”

Your email address will not be published. Required fields are marked *